MR imaging of Crohn disease: use of perflubron as a gastrointestinal contrast agent

This study was undertaken to evaluate the use of perflubron (perfluorooctylbromide) as an oral contrast agent for magnetic resonance (MR) imaging of patients with Crohn disease. MR examinations were performed before and after perflubron administration in 12 patients with documented Crohn disease. Gl...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 4; no. 3; p. 491
Main Authors Anderson, C M, Brown, J J, Balfe, D M, Heiken, J P, Borrello, J A, Clouse, R E, Pilgram, T K
Format Journal Article
LanguageEnglish
Published United States 01.05.1994
Subjects
Online AccessGet more information

Cover

Loading…